The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes

The authors prospectively studied psychotropic prescribing practices and quality assurance data in 17 nursing homes in the Baltimore area to assess the impact of federal antipsychotic drug regulations. There was a 36% reduction in prescriptions for neuroleptics over 6 months, no increase in prescrip...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 1992-10, Vol.149 (10), p.1390-1392
Hauptverfasser:	ROVNER, BW, EDELMAN, BA, COX, MP, SHMUELY, Y
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioethics Biological and medical sciences Drug Prescriptions - statistics & numerical data Drug Utilization Drugs Federal Government Government Regulation Humans Legislation, Drug Life Sciences & Biomedicine Medical sciences Miscellaneous Neuropharmacology Nursing homes Nursing Homes - standards Pharmacology. Drug treatments Prospective Studies Psychiatry Psychotropic Drugs - therapeutic use Quality Assurance, Health Care Regulation Restraint, Physical Science & Technology Seasons Social research United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The authors prospectively studied psychotropic prescribing practices and quality assurance data in 17 nursing homes in the Baltimore area to assess the impact of federal antipsychotic drug regulations. There was a 36% reduction in prescriptions for neuroleptics over 6 months, no increase in prescriptions for sedative/hypnotics, and a small increase in prescriptions for antidepressants. The authors conclude that psychotropic drug prescribing practices and patient outcomes remain important areas of study in nursing homes.
ISSN:	0002-953X 1535-7228
DOI:	10.1176/ajp.149.10.1390